Latest News & Features
Americas
3D printing will shake up the world of intellectual property law, providing numerous opportunities for those who are prepared, but also risks to those who aren’t. 8 December 2016
Americas
President-elect Donald Trump’s announcement that he will withdraw the US from the Trans-Pacific Partnership is a “detriment” to US companies in terms of enforcing their patent rights in other jurisdictions. 8 December 2016
Big Pharma
Drugs companies that acquire other businesses should act cautiously after the deal has been completed, because of potential differences in patent strategy, an Eli Lilly counsel has said. 7 December 2016
Big Pharma
The Unified Patent Court Agreement has not quite reached a safe harbour yet, but it is close. 7 December 2016
Americas
The complications surrounding second medical use patents risks the pharmaceutical industry again becoming a “big, bad wolf”. 7 December 2016
Big Pharma
Intellectual property is the lifeblood of the life sciences industry and innovation is key, according to Nicola Dagg, head of Allen & Overy’s IP litigation practice in London. 7 December 2016
Americas
The Broad Institute of MIT and Harvard is appearing against the University of California, Berkeley (UCB), which is joined by the University of Vienna and Emmanuelle Charpentier, in a patent interference proceeding today. 6 December 2016
Americas
Astellas Pharma, Medivation and the regents of the University of California have collectively sued Actavis for alleged patent infringement over Xtandi, a treatment for prostate cancer. 6 December 2016
Americas
Anyone seeking a deal with a life sciences company must understand the value and potential risks of its IP, as Karen Mangasarian and Ryan Murphey of Ropes & Gray explain. 6 December 2016
Americas
Oral arguments in Life Technologies v Promega are due to take place tomorrow in the US Supreme Court to determine whether the US Court of Appeals for the Federal Circuit correctly defined “substantial portion”. 5 December 2016